| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -239,852 |
| Change in allowance for credit loss | -89,322 |
| Depreciation and amortization | 8,170 |
| Non cash lease expense | 18,317 |
| Accounts receivable | -255,391 |
| Inventories | -395,939 |
| Other current assets | 102,666 |
| Accounts payable | -206,810 |
| Accrued expenses | 113,953 |
| Change in operating lease liability | -17,733 |
| Deferred revenue | -50,451 |
| Other short-term and long-term liabilities | 72 |
| Net cash provided by operating activities | 85,008 |
| Purchase of equipment | 4,421 |
| Net cash used in investing activities | -4,421 |
| Repayment of note payable | 9,832 |
| Repayment of eidl loan | 767 |
| Net cash used in financing activities | -10,599 |
| Net increase in cash, cash equivalents and restricted cash | 69,988 |
| Cash and cash equivalents at beginning of period | 802,385 |
| Cash and cash equivalents at end of period | 872,373 |
ESCALON MEDICAL CORP (ESMC)
ESCALON MEDICAL CORP (ESMC)